OmniAb (OABI) Receivables - Other (2023 - 2026)

OmniAb (OABI) reported Receivables - Other of $3.5 million for Q1 2026, up 400.0% year-over-year from $700000.0 in Q1 2025, and up 337.5% quarter-over-quarter from $800000.0 in Q4 2025.

OmniAb (OABI) Receivables - Other (2023 - 2026) Analysis & Trends

OmniAb (OABI) has 4 years of Receivables - Other data on file, last reported at $3.5 million in Q1 2026.

  • Receivables - Other for Q1 2026 came in at $3.5 million, up 400.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 400.0% YoY), and the FY2025 annual result was $800000.0, down 69.23% from the prior year.
  • Receivables - Other advanced to $3.5 million in Q1 2026 per OABI's latest filing, from $800000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $3.5 million in Q1 2026 and troughed at $300000.0 in Q3 2025.
  • A 4-year average of $1.3 million and a median of $800000.0 in 2023 frame the typical range for Receivables - Other.
  • The sharpest annual moves came in 2025 and 2026: Receivables - Other sank 69.23% in 2025, then surged 400.0% in 2026.
  • A 4-year view of Receivables - Other shows it stood at $800000.0 in 2023, then soared by 225.0% to $2.6 million in 2024, then slumped by 69.23% to $800000.0 in 2025, then soared by 337.5% to $3.5 million in 2026.
  • Business Quant data shows OABI's Receivables - Other at $3.5 million in Q1 2026, $800000.0 in Q4 2025, and $300000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.50 Mn
Mar 31, 2026 3.50 Mn
Dec 31, 2025 800,000.00
Dec 31, 2025 800,000.00
Sep 30, 2025 300,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 700,000.00
Mar 31, 2025 700,000.00
Dec 31, 2024 2.60 Mn
Dec 31, 2024 2.60 Mn
Dec 31, 2023 800,000.00
Dec 31, 2023 800,000.00